
Results
25
Companies which are more than 50% undervalued based on analyst price target.
25 companies
Samsung Epis Holdings
Market Cap: ₩9.0t
A biotechnology company, manage the portfolio of biopharmaceutical products.
A0126Z0
₩379,000.00
7D
-6.0%
1Y
n/a
ABL Bio
Market Cap: ₩4.5t
A biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases.
A298380
₩79,700.00
7D
-8.2%
1Y
-1.5%
LigaChem Biosciences
Market Cap: ₩3.8t
A clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs.
A141080
₩104,400.00
7D
-9.3%
1Y
-26.0%
Voronoi
Market Cap: ₩3.2t
Researches, develops, and discovers small molecule kinase inhibitors in South Korea.
A310210
₩176,400.00
7D
0.9%
1Y
56.8%
ST PharmLtd
Market Cap: ₩2.1t
Provides manufacturing services for active pharmaceutical ingredient and intermediate.
A237690
₩99,300.00
7D
-7.2%
1Y
11.1%
Oscotec
Market Cap: ₩1.5t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩38,100.00
7D
-1.8%
1Y
15.6%
L&C BIOLTD
Market Cap: ₩1.4t
Operates as a research and development company in tissue regeneration medicine.
A290650
₩51,800.00
7D
-8.8%
1Y
69.6%
GC Biopharma
Market Cap: ₩1.4t
A biopharmaceutical company, develops and sells pharmaceutical drugs in South Korea and internationally.
A006280
₩125,600.00
7D
-3.0%
1Y
-3.6%
Seegene
Market Cap: ₩1.4t
Manufactures and sells molecular diagnostics products worldwide.
A096530
₩30,000.00
7D
-6.1%
1Y
12.4%
Daewoong Pharmaceutical
Market Cap: ₩1.4t
Develops, manufactures and commercializes pharmaceutical products in South Korea and internationally.
A069620
₩121,400.00
7D
-1.5%
1Y
-9.4%
HK inno.N
Market Cap: ₩1.2t
Engages in the pharmaceutical business in South Korea.
A195940
₩41,250.00
7D
-1.0%
1Y
-7.2%
Chong Kun Dang Pharmaceutical
Market Cap: ₩885.4b
Manufactures, markets, and sells medicines in South Korea and internationally.
A185750
₩67,300.00
7D
-1.3%
1Y
-16.7%
DongKook Pharmaceutical
Market Cap: ₩812.0b
Produces and sells pharmaceutical products in South Korea and internationally.
A086450
₩18,000.00
7D
-16.7%
1Y
4.9%
Boryung
Market Cap: ₩759.5b
Engages in the manufacture and sale of pharmaceutical products in South Korea and internationally.
A003850
₩9,120.00
7D
-0.7%
1Y
10.9%
AprilBioLtd
Market Cap: ₩723.5b
Develops long-acting type biobetter and antibody biologics.
A397030
₩26,300.00
7D
-7.7%
1Y
19.8%
Pharmicell
Market Cap: ₩682.8b
A biopharmaceutical company, develops and sells autologous drugs in South Korea and internationally.
A005690
₩11,920.00
7D
0%
1Y
10.6%
Dong-A Socio Holdings
Market Cap: ₩584.7b
Engages in the pharmaceutical business in South Korea.
A000640
₩90,400.00
7D
-4.2%
1Y
-10.9%
Dong-A ST
Market Cap: ₩354.2b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩37,350.00
7D
-2.2%
1Y
-12.5%
Humedix
Market Cap: ₩263.7b
Engages in the manufacture and sale of various pharmaceutical products in South Korea.
A200670
₩25,550.00
7D
-8.4%
1Y
-52.5%
BINEX
Market Cap: ₩209.2b
Operates as a pharmaceutical company in South Korea.
A053030
₩6,570.00
7D
-12.4%
1Y
-56.0%
Whan In PharmLtd
Market Cap: ₩183.5b
Manufactures and sells various pharmaceutical products in South Korea.
A016580
₩9,970.00
7D
-2.0%
1Y
-10.7%
Daewon Pharmaceutical
Market Cap: ₩166.3b
A pharmaceutical company, manufactures and sells medicines and medical supplies in South Korea.
A003220
₩7,770.00
7D
-2.6%
1Y
-40.2%
Daihan PharmaceuticalLtd
Market Cap: ₩153.8b
Engages in the manufacture and sale of therapeutic drugs in South Korea.
A023910
₩26,150.00
7D
-3.1%
1Y
-11.7%
Samil PharmaceuticalLtd
Market Cap: ₩132.9b
Engages in the manufacture and sale of pharmaceuticals in South Korea.
A000520
₩6,320.00
7D
-6.9%
1Y
-34.8%
Macrogen
Market Cap: ₩131.0b
Provides precision medicine and bio-engineering healthcare services in Korea and internationally.
A038290
₩12,080.00
7D
-4.1%
1Y
-22.6%